AACR: Personalized Vaccine for Cancer Tolerated, Feasible
Vaccine well tolerated in 13 patients; vaccine showed potential benefit in patients with solid tumors, multiple myeloma in phase 1 trial
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Oncology, Pathology, Conference News, Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Conferences | Myeloma | Pathology | Vaccines